User profiles for Simon M. Laws
 | Simon M. LawsEdith Cowan University Verified email at ecu.edu.au Cited by 8758 |
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE …
Alzheimer's disease (AD) is the most commonly diagnosed form of dementia in the elderly.
Predominantly this disease is sporadic in nature with only a small percentage of patients …
Predominantly this disease is sporadic in nature with only a small percentage of patients …
The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?
The beta amyloid (Aβ) protein is a key molecule in the pathogenesis of Alzheimer’s disease
(AD). The tendency of the Aβ peptide to aggregate, its reported neurotoxicity, and genetic …
(AD). The tendency of the Aβ peptide to aggregate, its reported neurotoxicity, and genetic …
[HTML][HTML] Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL …
Worldwide there are over 46 million people living with dementia, and this number is expected
to double every 20 years reaching about 131 million by 2050. The cost to the community …
to double every 20 years reaching about 131 million by 2050. The cost to the community …
[HTML][HTML] Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture
Genetic association studies have identified 44 common genome-wide significant risk loci for
late-onset Alzheimer’s disease (LOAD). However, LOAD genetic architecture and prediction …
late-onset Alzheimer’s disease (LOAD). However, LOAD genetic architecture and prediction …
Blood-based protein biomarkers for diagnosis of Alzheimer disease
… Author Contributions: Drs Doecke and Laws contributed equally to this manuscript. Study
concept and design: Doecke, Wilson, Bush, Ellis, Head, Ames, Masters, and Martins. …
concept and design: Doecke, Wilson, Bush, Ellis, Head, Ames, Masters, and Martins. …
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
Previous studies suggest physical activity improves cognition and lowers Alzheimer's
disease (AD) risk. However, key AD pathogenic factors that are thought to be influenced by …
disease (AD) risk. However, key AD pathogenic factors that are thought to be influenced by …
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging
Objective: There is mounting evidence for the contribution of apoE to the pathophysiology of
Alzheimer disease (AD). Studies also indicate that plasma apoE levels may reflect disease …
Alzheimer disease (AD). Studies also indicate that plasma apoE levels may reflect disease …
[HTML][HTML] Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease
We integrated lipidomics and genomics to unravel the genetic architecture of lipid metabolism
and identify genetic variants associated with lipid species putatively in the mechanistic …
and identify genetic variants associated with lipid species putatively in the mechanistic …
The relationship between sleep quality and brain amyloid burden
Study Objectives: To evaluate the association between self-reported sleep quality and
levels of brain β-amyloid (Aβ) burden, and to determine the effect of the apolipoprotein E (APOE) …
levels of brain β-amyloid (Aβ) burden, and to determine the effect of the apolipoprotein E (APOE) …
Plasma amyloid-β as a biomarker in Alzheimer's disease: the AIBL study of aging
Amyloid-β (Aβ) plays a central role in the pathogenesis of Alzheimer’s disease (AD) and has
been postulated as a potential biomarker for AD. However, there is a lack of consensus as …
been postulated as a potential biomarker for AD. However, there is a lack of consensus as …
